Abstract:The glioblastoma microenvironment is dominated by tumour‐associated macrophages (TAMs). In the tumour core, monocyte‐derived TAMs accumulate and exhibit anti‐inflammatory and immune‐suppressive expression profiles. At the periphery of the tumour, brain microglia‐derived TAMs predominate and exhibit pro‐inflammatory and interferon states. Depletion or repolarisation of selected TAM subsets may be key to effective immunotherapy. Glioblastoma is the most common primary malignant tumour of the central nervous system and remains uniformly and rapidly fatal. The tumour‐associated macrophage (TAM) compartment comprises brain‐resident microglia and bone marrow‐derived macrophages (BMDMs) recruited from the periphery. Immune‐suppressive and tumour‐supportive TAM cell states predominate in glioblastoma, and immunotherapies, which have achieved striking success in other solid tumours have consistently failed to improve survival in this 'immune‐cold' niche context. Hypoxic and necrotic regions in the tumour core are found to enrich, especially in anti‐inflammatory and immune‐suppressive TAM cell states. Microglia predominate at the invasive tumour margin and express pro‐inflammatory and interferon TAM cell signatures. Depletion of TAMs, or repolarisation towards a pro‐inflammatory state, are appealing therapeutic strategies and will depend on effective understanding and classification of TAM cell ontogeny and state based on new single‐cell and spatial multi‐omic in situ profiling. Here, we explore the application of these datasets to expand and refine TAM characterisation, to inform improved modelling approaches, and ultimately underpin the effective manipulation of function.

Research status of glioblastoma-associated microglia

Interactions between microglia and glioma in tumor microenvironment

Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma

Macrophages/Microglia in the Glioblastoma Tumor Microenvironment

The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential

Tumor-associated macrophage-related strategies for glioma immunotherapy

Microglia and macrophages in glioblastoma: landscapes and treatment directions

Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities

Csig-12. glioma microenvironment: functions, molecular mechanisms, and therapeutic implications

Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential

Dynamics of glioma-associated microglia and macrophages reveals their divergent roles in the immune response of brain

Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment

Perspectives on Microglia-Based Immune Therapies Against Glioblastoma

Research Progress in Immunotherapy of Gliomas

The roles of glioma-associated macrophages/microglia and potential targets for anti-glioma therapy

Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma

From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review

Research Progress of MicroRNA in Glioma

Immune response in glioma’s microenvironment

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy

Immunotherapy of Glioblastoma: Recent Advances and Future Prospects